Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/1995
12/05/1995US5472978 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
12/05/1995US5472959 Hypotensive agents, congestive heart failure
11/1995
11/30/1995WO1995032218A1 Neurotensin antagonist peptides
11/30/1995WO1995032217A1 Peptide antagonist intermediates of neurotensin
11/30/1995WO1995032191A1 Inhibitors of farnesyl-protein transferase
11/30/1995WO1995032173A1 Compound bearing two 2,6-diiodophenol-4-yl groups and diagnostic drug for iodine allergy
11/30/1995CA2190846A1 Inhibitors of farnesyl-protein transferase
11/29/1995EP0684259A1 L-lysyl-glycyl-L-histidine and therapeutic agent for wound healing containing the same
11/29/1995EP0684258A2 Tripeptide antithrombotic agents
11/29/1995EP0684257A1 Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them
11/28/1995US5470960 Phenylalanine-glycine derivatives, process for preparation thereof, and pharmaceutical composition containing said derivatives
11/28/1995US5470951 Alzheimer's
11/28/1995US5470949 Method for making amino acid glycosides and glycopeptides
11/28/1995US5470834 Metalloproteinase enzyme inhibitors for arthritis, rheumatism and cancers
11/28/1995US5470833 Vasodilators, bronchodilators
11/28/1995US5470832 Inhibitors of geranylgeranyl-protein transferase
11/28/1995US5470831 Angiogenic peptides
11/28/1995CA2150334A1 L-lysyl-glycyl-l-histidine and therapeutic agent for wound healing containing the same
11/28/1995CA1337670C Cell growth inhibitory substance
11/28/1995CA1337654C Fused tricyclic lactams as antihypertensive agents
11/23/1995WO1995031474A1 Compounds for reversing drug resistance
11/23/1995WO1995031221A1 Somatostatin binding peptide-metal chelate conjugates
11/23/1995CA2189978A1 Compounds for reversing drug resistance
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995EP0682654A1 Benzo-fused lactams promote release of growth hormone
11/22/1995EP0659188A4 Methods for the synthesis of phosphonate esters.
11/22/1995CN1112125A Acyloxyhexanoic acid derivatives
11/22/1995CN1112117A Imidazole-containing inhibitors of farnesyl protein transferase
11/21/1995US5468745 For administering to patients suffering from hypertension or congestive heart failure
11/21/1995US5468733 For treating cancer
11/21/1995US5468732 Phosphorus containing renin inhibitors
11/21/1995US5468731 Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
11/21/1995US5468730 Methods for the treatment of non-IgE-mediated diseases
11/21/1995US5468480 Pharmaceutical composition of purified chymopapain
11/16/1995WO1995030740A1 Process for obtaining micro-organisms containing peptide amidase, micro-organisms obtained therewith, peptide amidases contained in them and use thereof
11/16/1995WO1995030694A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties
11/16/1995WO1995030691A1 New peptide active substance and production thereof
11/16/1995WO1995030690A1 Novel tetrapeptides, their manufacture and use
11/16/1995WO1995030689A1 Improved method for the preparation of an aspartame-derived compound useful as a sweetener
11/16/1995WO1995030688A1 N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-HEXAHYDROPHENYLALANINE 1-METHYL ESTER USEFUL AS A SWEETENING AGENT AND METHOD OF PREPARATION
11/16/1995WO1995030687A1 Neurokinine (tachykinine) antagonists
11/16/1995WO1995030430A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
11/16/1995WO1995028418A3 Tachykinin antagonists
11/16/1995WO1995025118A3 Inhibitors of sh2 domain interactions
11/16/1995DE19516018A1 Isolation of microorganisms able to produce peptide amidase by selection on two amide contg. media
11/16/1995CA2189764A1 Neurokinine (tachykinine) antagonists
11/16/1995CA2189558A1 N-¬n-(3,3-dimethylbutyl)-l-.alpha.-aspartyl|-l-hexahydrophenylalanine 1-methyl ester useful as a sweetening agent and method of preparation
11/16/1995CA2188670A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties
11/15/1995EP0431146B1 Radionuclide metal chelates for the radiolabeling of proteins
11/15/1995CN1111630A Adhesion receptor antagonists
11/09/1995WO1995029708A1 TECHNETIUM-99m LABELED IMAGING AGENTS
11/09/1995WO1995029691A1 Proline phosphonate derivatives
11/09/1995WO1995029689A1 N-carboxyalkyl derivatives as antidegenerative active agents
11/09/1995DE4445939A1 Neue Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen (II) New amino acid derivatives, to processes for their preparation containing these compounds and pharmaceutical compositions (II)
11/09/1995DE4415998A1 Neue Tetrapeptide, ihre Herstellung Verwendung New tetrapeptides, their preparation using
11/09/1995DE4415997A1 Neuer peptidischer Wirkstoff und dessen Herstellung New peptidic drug and its preparation
11/09/1995CA2189420A1 Technetium-99m labeled imaging agents
11/08/1995EP0680973A1 Peptides, process to prepare them and their use
11/08/1995EP0680972A1 Trifluoromethylketone peptide derivatives, process for their preparation and pharmaceutical compositions comprising them
11/08/1995EP0680971A1 Dry crystals of alpha-L-aspartyl-L-phenylalanine methyl ester having improved solubility
11/08/1995EP0680513A1 Lysosomal targeting of immunogens
11/08/1995EP0680469A1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same
11/07/1995US5464934 Metal chelates as spacer compounds in biologically active peptides
11/07/1995US5464933 Synthetic peptide inhibitors of HIV transmission
11/07/1995US5464825 Metabolism, transport, protection
11/07/1995US5464821 And intraocular hypertension
11/07/1995US5464820 Specific inhibitors of tissue kallikrein
11/07/1995US5464819 Physiologically active peptide having immunoregulatory activities
11/07/1995CA1337519C Antibiotic ge 2270
11/06/1995CA2148650A1 Peptides derived from trifluoromethylketones; process for preparing the same and pharmaceutical compositions containing them
11/02/1995WO1995029190A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995WO1995029189A1 FACTOR Xa INHIBITORS
11/02/1995WO1995029182A1 Cephalosporin synthesis
11/02/1995WO1995028838A1 Modified amino acids for drug delivery
11/02/1995EP0679631A1 Biaromatic acetylated, an adamantyl group containing compounds, pharmaceutical and cosmetic compositions containing them and their use
11/02/1995EP0679403A1 Preventive and remedy for allergic disease
11/02/1995EP0679161A1 Thiazolidine derivatives, preparation thereof and drugs containing same
11/02/1995EP0679153A1 Amino acids and peptides having modified terminals
11/02/1995EP0679092A1 Cytokine restraining agents
11/02/1995CA2533837A1 Cephalosporin synthesis
11/02/1995CA2188470A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995CA2188467A1 Modified amino acids for drug delivery
11/01/1995CN1030193C N,N'-(1-oxo-1,2-ethanediyl)-bis (aspartic acid), salts and use in detergent compositions
10/1995
10/31/1995US5463122 Arylthio compounds
10/31/1995US5462964 Dipeptide boronic acid inhibitors of trypsin-like enzymes
10/31/1995US5462939 Treating infectious diseases, septic shock, respiratory diseases, inflammatory conditions, autoimmune diseases, bone diseases
10/31/1995US5462933 Modified bile acid conjugates, and their use as pharmaceuticals
10/31/1995US5462928 Antiarthritic agents, aids, therapy for transplant rejection
10/29/1995CA2147925A1 Pseudopeptides derived from neurokinins; process for preparing the same and pharmaceutical compositions containing them
10/26/1995WO1995028426A2 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995WO1995028420A1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
10/26/1995WO1995028419A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995WO1995028418A2 Tachykinin antagonists
10/26/1995WO1995028417A1 Phosphonyldipeptides useful in the treatment of cardiovascular diseases
10/26/1995WO1995028416A1 Aziridine derivatives, their production and use
10/26/1995CA2188162A1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
10/26/1995CA2187642A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995CA2187451A1 Aziridine derivatives, their production and use
10/26/1995CA2186900A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995CA2183991A1 Tachykinin antagonists
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 307